Bone marrow may play an unexpected role in disease progression
Alzheimer’s Beyond the Brain: A discovery may change how we understand the progression of Alzheimer’s disease. Researchers have found disease-associated changes in the bone marrow, revealing an unexpected connection between the peripheral immune system and the brain.

For decades, Alzheimer’s disease has been studied primarily as a condition of the brain. Amyloid-beta plaques, tau protein, neurons, brain inflammation, and memory changes are among the main subjects investigated by neuroscience.
Mas uma nova pesquisa publicada em September 8, 2026 na revista Nature Neuroscience aponta para uma possibilidade surpreendente: a progressão da doença também pode estar relacionada ao que acontece fora do cérebro — especificamente, na medula óssea.
🧠 What does bone marrow have to do with Alzheimer’s?
Bone marrow produces various blood cells, including cells of the immune system.
Entre elas estão os monocytes, which can develop into macrophages and participate in the immune response.
Estudos anteriores já haviam mostrado que macrófagos derivados de monocytes podem atuar como uma espécie de reforço para as células imunológicas residentes no cérebro, especialmente a micróglia.
The new study investigated why these protective cells do not reach the brain in sufficient numbers during Alzheimer’s disease.
The answer was unexpected.
🔬 The problem may begin with the production of immune cells
In Alzheimer’s models, the researchers observed a change in myelopoiesis, the process responsible for producing myeloid-lineage cells in the bone marrow.
This change was associated with an abnormal response involving type I interferon (IFN-I).
In other words, the disease appears to trigger signals in the body that alter how the bone marrow functions.
Como consequência, os monocytes produzidos apresentam alterações e o recrutamento de células derivadas deles para o cérebro é prejudicado.
This may be particularly important because the brain loses some of this immune support precisely when it may be needed to respond to neurodegeneration.
🧬 A connection between the body and the brain
This finding reinforces an important shift in how neuroscience understands neurodegenerative diseases.
The brain does not function in isolation.
There is constant communication between:
🧠 brain ↔ 🩸 blood ↔ 🦴 bone marrow ↔ 🛡️ immune system
Changes in one of these systems can affect the others.
In the study, the researchers found evidence of similar changes in circulating cells from patients with Alzheimer’s disease, strengthening the relevance of the connection observed in experimental models.
🧪 What if this signal could be corrected?
This is one of the most interesting aspects of the research.
In experiments using the animal model of Alzheimer’s disease known as 5xFAD, the researchers blocked type I interferon signaling.
O bloqueio restaurou a produção de células mieloides mais saudáveis e aumentou o recrutamento de macrófagos derivados de monocytes para o cérebro.
More importantly, the animals showed improvements in disease-associated features and brain pathology.
Similar results were also obtained using bone marrow genetically unable to respond through the type I interferon receptor.
This suggests that peripheral immune signaling could be a potential target for future therapeutic strategies.
⚠️ But this is not yet a treatment for Alzheimer’s disease
It is important to distinguish a scientific discovery from a clinical application.
The therapeutic results described in the study were obtained primarily in animal models of Alzheimer’s disease.
Embora alterações semelhantes tenham sido identificadas em monocytes de pessoas com Alzheimer, ainda são necessários estudos adicionais para determinar se interferir nessa via será seguro e eficaz em seres humanos.
Therefore, the study does not mean that Alzheimer’s disease is caused by the bone marrow, nor that a treatment based on this mechanism is currently available.
What it demonstrates is something more fundamental:
disease progression may involve systemic processes that occur outside the brain.
🌎 A new perspective on neurodegenerative diseases
The finding fits an increasingly important trend in neuroscience: understanding the brain as part of an integrated organism.
The immune system, metabolism, circulation, gut, muscles, and other organs can influence brain function.
In Alzheimer’s disease, this may represent a shift in perspective.
Some answers to a disease that profoundly affects the brain may lie, at least in part, outside it.
And bone marrow has now gained a new place in this line of investigation.
🔬 Neuroscience is expanding its boundaries
The study published in Nature Neuroscience shows how Alzheimer’s research is moving beyond an exclusive focus on what happens inside the brain.
Understanding the brain may also mean understanding the whole body.
This integration of neuroscience, immunology, and systems biology may open new avenues for understanding and perhaps, in the future, treating neurodegenerative diseases.
Scientific source: Abellanas, M. A. et al. Bone marrow myelopoiesis dysfunction in Alzheimer’s disease limits monocyte homing to the brain and drives disease progression. Nature Neuroscience, publicado em September 8, 2026. DOI: 10.1038/s41593-026-02417-7.
IAN editorial note: the therapeutic findings described are experimental and do not currently constitute an established clinical treatment for Alzheimer’s disease.
